How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,237 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2201. Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

: Treatment Official Title: A Phase IIIb, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Dose Optimization Study, Designed to Evaluate the Efficacy and Safety of MTS in Adolescents Aged 13-17 Years With ADHD Study Start Date : July 2007 Actual Primary Completion Date : May 2008 Actual Study Completion Date : May 2008 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Methylphenidate (...) Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2007 Clinical Trials

2202. A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration (...) or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents (ADHD LIFE) The safety and scientific validity of this study is the responsibility of the study sponsor

2007 Clinical Trials

2203. Procedural Learning in Participants With ADHD

with ADHD: The Effect of Methylphenidate Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Outcome Measures Go to Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision (...) Procedural Learning in Participants With ADHD Procedural Learning in Participants With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Procedural Learning in Participants With ADHD The safety

2007 Clinical Trials

2204. A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

to 55, With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : July 2007 Actual Primary Completion Date : April 2008 Actual Study Completion Date : April 2008 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: MK-0249 Total time in the study will be ~10 weeks. Drug: MK0249 MK-0249, 10 mg per day was taken orally daily. If patients were unable to tolerate 10 mg per day (...) A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2007 Clinical Trials

2205. A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators

Start Date : April 2007 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : Driver Safety (DS) Score averaged over 3 driving assessments at one interim and one final visit. Secondary Outcome Measures : Simulated DS scores & individual components, averaged over the testing times. Interim & final visits: ADHD-RS-IV, CGI-I and Self-Rating of DS Performance Questionnaire. TEAEs, vital signs, lab (...) A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2007 Clinical Trials

2206. Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

participants Observational Model: Cohort Time Perspective: Prospective Official Title: Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS) Actual Study Completion Date : February 2006 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Group/Cohort Intervention/treatment 001 Other: Observational treatment compliance survey Observational treatment compliance survey Outcome Measures Go to Primary Outcome Measures : The change from survey day (...) Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS) Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Compliance

2007 Clinical Trials

2207. Methylphenidate for Treating Children With ADHD and Tourette Syndrome

Masking: Double Primary Purpose: Treatment Official Title: Methylphenidate Treatment of ADHD in Children With Tourette Syndrome Study Start Date : February 2000 Actual Primary Completion Date : June 2004 Actual Study Completion Date : January 2007 Resource links provided by the National Library of Medicine related topics: related topics: available for: Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : ADHD symptoms Oppositional and aggressive behavior Frequency (...) Methylphenidate for Treating Children With ADHD and Tourette Syndrome Methylphenidate for Treating Children With ADHD and Tourette Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Methylphenidate

2007 Clinical Trials

2208. PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)

evidence for stimulation of central dopaminergic receptors. Study Design Go to Layout table for study information Study Type : Observational Actual Enrollment : 16 participants Time Perspective: Other Official Title: PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : September 15, 2006 Study Completion Date : November 27, 2012 Resource links provided by the National Library of Medicine (...) PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD) PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. PET

2006 Clinical Trials

2209. Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved (...) Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our

2006 Clinical Trials

2210. Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Trial) Actual Enrollment : 142 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: An Open-label, Behavioral-treatment-controlled Evaluation of the Effects of Extended Release Methylphenidate on the Frequency of Cytogenetic Abnormalities in Children 6 - 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : November 2006 Actual Primary Completion Date : March 2008 Resource (...) Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2006 Clinical Trials

2211. Brain Dopamine Function in Adults With ADHD

information Study Type : Interventional (Clinical Trial) Actual Enrollment : 24 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Basic Science Official Title: Brain Dopamine Function in Adults With ADHD Study Start Date : February 2006 Actual Primary Completion Date : March 2009 Actual Study Completion Date : April 2009 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Intervention Details: Drug (...) Brain Dopamine Function in Adults With ADHD Brain Dopamine Function in Adults With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Brain Dopamine Function in Adults With ADHD (Brookhaven) The safety

2007 Clinical Trials

2212. The Reinforcing Mechanisms of Smoking in Adult ADHD

Date : June 2010 Actual Study Completion Date : June 2010 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: ADHD medication versus placebo For the ADHD medication condition, participants received their usual dosage of their usual ADHD medication (e.g., Dextroamphetamine; Amphetamine mixed salts; Atomoxetine; O-Methylphenidate; Lisdexamfetamine). For the placebo condition, a placebo pill was administered (...) The Reinforcing Mechanisms of Smoking in Adult ADHD The Reinforcing Mechanisms of Smoking in Adult ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Reinforcing Mechanisms of Smoking in Adult ADHD

2007 Clinical Trials

2213. Pilot Study of Vyvanseâ„¢ In ADHD Adolescents at Risk for Substance Abuse

(Lisdexamfetamine Dimesylate) in Adolescents (Ages 11-15) With ADHD and an Older Sibling With ADHD and Substance Dependence Study Start Date : March 2008 Actual Primary Completion Date : January 2010 Actual Study Completion Date : March 2010 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Open Label Vyvanse Open Label Vyvanse (lisdexamphetamine) in doses of 30-70 mgs over 8 weeks in younger siblings (...) Pilot Study of Vyvanseâ„¢ In ADHD Adolescents at Risk for Substance Abuse Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pilot Study

2007 Clinical Trials

2214. Nicotine and Behavior in Adult ADHD

: December 2009 Actual Study Completion Date : December 2009 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: 4 Drug: Nicotine 21 mg nicotine patches for smokers for 2 days 7 mg nicotine patches for nonsmokers for 2 days Other: Placebo Placebo Patch Outcome Measures Go to Primary Outcome Measures : ADHD Symptoms [ Time Frame: 4 days ] Mean percentage of endorsement for each electronic diary item (percent (...) Nicotine and Behavior in Adult ADHD Nicotine and Behavior in Adult ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Nicotine and Behavior in Adult ADHD The safety and scientific validity of this study

2007 Clinical Trials

2215. Enhancing ADHD Driving Performance With Stimulant Medication

Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 14 participants Allocation: Randomized Intervention Model: Crossover Assignment Masking: None (Open Label) Official Title: Enhancing ADHD Driving Performance With Stimulant Medication Study Start Date : July 2007 Estimated Primary Completion Date : July 2009 Estimated Study Completion Date : July 2009 Resource links provided by the National Library of Medicine related (...) Enhancing ADHD Driving Performance With Stimulant Medication Enhancing ADHD Driving Performance With Stimulant Medication - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Enhancing ADHD Driving Performance

2007 Clinical Trials

2216. Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00568685 Recruitment Status : Completed First Posted : December 6, 2007 Results First Posted

2007 Clinical Trials

2217. Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00406354 Recruitment Status : Completed First Posted : December 4, 2006 Results First Posted

2006 Clinical Trials

2218. A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Disorder (ADHD) Study Start Date : October 2006 Actual Primary Completion Date : June 2007 Actual Study Completion Date : June 2007 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Placebo Comparator: 1 Drug: Placebo Subjects will take placebo QD, BID for 4-6 weeks Experimental: 2 Drug: ABT-089 Subjects will take 2 mg QD, 5 mg QD, 15 mg QD, 40 mg QD, 40 mg BID for 4-6 weeks Outcome Measures Go to Primary Outcome Measures (...) A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You

2006 Clinical Trials

2219. Atomoxetine Treatment for ADHD and Marijuana Dependence

Atomoxetine Treatment for ADHD and Marijuana Dependence Atomoxetine Treatment for ADHD and Marijuana Dependence - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Atomoxetine Treatment for ADHD and Marijuana (...) Drug: Atomoxetine Procedure: Motivational enhancement therapy Drug: Placebo Phase 2 Detailed Description: The purpose of this study is to determine whether the medication atomoxetine, or Strattera, plus 3 sessions of counseling can help people to reduce the symptoms of ADHD and to help cut back on their marijuana use. Participation in the study is approximately 12 weeks of medication treatment and doctor's visits once a week. The first 2 visits consist of evaluations to determine if you qualify

2006 Clinical Trials

2220. SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. SPD503 (Guanfacine (...) Hydrochloride) in ADHD Plus Oppositional Symptoms The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00367835 Recruitment Status : Completed First Posted : August 23, 2006 Results First Posted : November 26, 2009 Last Update Posted : October 13, 2010 Sponsor: Shire Information provided by: Shire Study Details

2006 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>